Navigation Links
SIGVARIS USA Extends Educational Efforts in Healthy Advice's Skin Care Network
Date:9/1/2009

"We are pleased that SIGVARIS has chosen to increase their participation in Healthy Advice Networks," added Gregg Gentile, Executive Vice President, Business Development, Specialty Networks. "Patients are focused on their health in the dermatologist's office and will take advantage of the opportunity to discuss effective prevention and management of venous disorders. In this challenging business environment, it is more important than ever to target the right patient population at the right time with the right message. As SIGVARIS has found with our Skin Care Network, and previously with our Women's Health Network, our specialty networks allow manufacturers to deliver disease-specific information to patients and specialists."

Healthy Advice Networks is the largest and fastest growing health-information company in the industry and is planning to launch another primary care network, as well as several new programs targeted to both physicians and patients in 2010. The company delivers patient-education programs in primary care, cardiology, women's health, pediatric, gastroenterology, urology, dermatology, and rheumatology practices.

About Healthy Advice Networks

Healthy Advice Networks' mission is to help consumers and healthcare professionals make more informed health decisions by providing trusted, relevant and easy-to-understand health information when and where they need it. Over 50,000 primary care and specialty physicians throughout the U.S. have chosen Healthy Advice as their patient-education provider, making Healthy Advice the largest and fastest growing health-information company with programs in both the physician waiting room and exam room. The award-winning programs are sponsored by leading pharmaceutical and health and wellness brands. For sponsors, Healthy Advice provides a proven way to educate patients and physicians at the time treatment de
'/>"/>

SOURCE Healthy Advice Networks
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Elpac Power System Extends Energy Star Portfolio with 65-Watt External Power Supply
2. FDA extends review of Pennsaid(R) diclofenac sodium topical solution
3. NutraCea Announces Additions to Management Team; Chief Operating Officer Extends Employment Contract
4. Booth Radiology Extends and Elevates Partnership With AMICAS
5. Duane Reade Holdings, Inc. Amends Terms and Extends Deadlines for Previously Announced Cash Tender Offers for Senior Secured Floating Rate Notes and Senior Subordinated Notes
6. CareTech Extends IT Outsourcing Contract with The Christ Hospital
7. NCI Renews Mayo Clinic Cancer Center Support Grant, Extends Comprehensive Status
8. NCI renews Mayo Clinic Cancer Center support grant, extends comprehensive status
9. MasterCard Extends Agreement With OptumHealth
10. Gentiva(R) Health Services Acquisition Extends Certificate-of-Need Coverage in West Virginia
11. Cellular Technology Extends the Boundaries of E-healthcare, Says Frost & Sullivan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ogist Closer to Understanding Brain Wiring and Dis...wire/ -- Dr. Jeremy Schmahmann, Professor of Neuro...the Massachusetts General Hospital in Boston, on T...esearch on the new field of study called "Connecti..., Dr. Schmahmann is an award-winning leader in t...
(Date:11/20/2009)...Nov. 20 The United Stat... to make essential changes its health reform bill ...funding and conscience protection on abortion, pro...ude strong provisions for adequate affordability. ...ll an "enormous disappointment" that creates new a...
(Date:11/20/2009)... Nov. 20 Rates of infect...ed in late October, but the pandemic flu virus con...age groups, including the elderly, according to a ...: DGX ), the world,s leading provider of diagnos...ts most recent Quest Diagnostics Health Trends(TM)...
(Date:11/20/2009)...ael, November 20 Cardio ...ww.CVSLMEDICAL.COM , a leading,developer of advanc...ced that,the company,s Board of Directors has deci...ada and the Far East for its proprietary next-gene...gioplasty (PCTA) procedures. , Cardio Vas...
(Date:11/20/2009)...v. 20 SIRIUS XM Radio ...dcast Doctor Radio Reports: What Every Women Ne... hosted by veteran journalist Perri Peltz. ,, ...19/NYTU044LOGO ) ,, Doctor Radio Reports: Wh...l air November 21 live at 10:00 am ET on Doctor ...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5
...ecently approved of a new prescription treatment f...s almost everybody. Gingivitis is an inflammation ...ing gums. It is believed that plaque-forming bacte...uction in the inflammation associated with gingivi...
...rth weight may be at heightened risk// of cardiova...as well as for the fathers. In a research don...rt that poor fetal growth that leads to low birth ... children with low birth weight may also be at mor...
...cancers are preventable by changes in our life sty...osing excess weight also helps. To lose weight one...ncer Institute in US recently approved the dietary...ioxidants and protect the DNA from damage by free-...
...uggested that patients going for PET or CT scan sh...nterferes with PET/CT image results when there is ...university presented his study that looks at the ...l conference held this month in Toronto. Usua...
...er pills based treatment resulted in the lowest ra... the groups of African-Americans and Americans. No...ugs can benefit the patients with diabetes who suf...atment to Prevent Heart Attack Trial (ALLHAT) stud...
...f Internal Medicine obese women with breast cancer... study was conducted to determine treatment patter...nt chemotherapy for breast cancer. Adjuvant chemot... Data on patients with early stage breast canc...
Other Medicine News:Health News:Top Ten Super Food Items That Can Help In Avoiding Cancer , 2Health News:Obese women with breast cancer may be under treated., 2
(Date:11/20/2009)...tCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today ...utive Officer, and Greg Browne, Chief Financial Of...ay Health Care Conference in New York on Wednesday...e session and webcast will be audio only and no fo... host a webcast of the presentation live and by re...
(Date:11/20/2009)...swire-FirstCall/ -- BD (Becton, Dickinson and Comp... of its acquisition of HandyLab, Inc., an Ann Arbo...ctures molecular diagnostic assays and automation ...unced an exclusive agreement for BD to develop and...guar(TM) platform, the first fully integrated mole...
(Date:11/20/2009)...re-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Boa...wn as DOR BioPharma, Inc., a late-stage biotechnol...consortium to develop thermostable technology to a.... Soligenix received a $9.4 million grant from the...ases (NIAID), a division of the National Institute...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Dr M Group Selects Health Robotics Technology Over RIVA for all of its I V Compounding Centers in South East Asia 14017 1Dr M Group Selects Health Robotics Technology Over RIVA for all of its I V Compounding Centers in South East Asia 14017 2Dr M Group Selects Health Robotics Technology Over RIVA for all of its I V Compounding Centers in South East Asia 14017 3Dr M Group Selects Health Robotics Technology Over RIVA for all of its I V Compounding Centers in South East Asia 14017 4Communication problems in dementia care cause physical strain 57029 1Communication problems in dementia care cause physical strain 57029 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 1Diabetes drug kills cancer stem cells in combination treatment in mice 9909 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 3
...cation is June 3, 2009 - , , EXTON, Pa., Feb. 3 ...d (Nasdaq: VPHM ) today announced that the U.S. ...ority review for Cinryze C1 Inhibitor (human) as a...ema (HAE). The supplemental Biologics License App...1, 2008, was based on a re-analysis and resubmiss...
...ch designed to help improve medication adherence t..., WOONSOCKET, R.I., Feb. 3 /PRNewswire/ -- A s... found that nearly half of patients hospitalized f...d drug therapies, significantly increasing their r...s. The study found that among those patients who w...
Other Medicine Technology:FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 2CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 3CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year 4
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: